Navigation Links
Ikaria Receives Award for Excellence by New Jersey Business & Industry Association
Date:10/21/2009

CLINTON, N.J., Oct. 21 /PRNewswire/ -- Ikaria Holdings, Inc. today announced that it has been awarded the 2009 Award for Excellence in Business Expansion by the New Jersey Business & Industry Association (NJBIA), the largest state-run employer association in the United States. Ikaria earned the award based on criteria including increased productivity and revenues, as well as the net creation of new jobs.

"We are delighted that the New Jersey Business & Industry Association has recognized Ikaria for its contribution to the economic growth of New Jersey," said Daniel Tasse, Chairman and CEO of Ikaria. "This award acknowledges the strides we've made through strategic hiring of key positions in building a strong and sustainable business that is uniquely devoted to delivering novel treatments to fulfill the unmet medical needs of critically ill patients."

Ikaria was honored at the Annual NJBIA Awards Dinner on October 20, 2009.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a biotherapeutics company whose acute care products and therapies address the significant unmet needs of critically ill patients. The company's lead product, INOMAX® (nitric oxide) for inhalation, is the only FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns, and also is marketed in Canada, Europe, Latin America, Australia, Japan and Mexico. Ikaria is engaged in new and ongoing clinical development of INOMAX, carbon monoxide for inhalation and hydrogen sulfide. Ikaria also acquired the North American rights to terlipressin, which currently is under review by the FDA for the treatment of hepatorenal syndrome Type 1. The company also recently acquired the exclusive worldwide licenses to BL-1040, a potential breakthrough treatment for preventing pathological cardiac remodeling following acute myocardial infarction, as well as to a portfolio of investigational compounds focused o
'/>"/>

SOURCE Ikaria Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
2. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
3. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
4. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
7. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
8. CryoCor Receives FDA Approval for Right Atrial Flutter
9. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
10. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
11. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014  Today the US Surgeon General issued ... sun tanning or sun burns stating they can lead directly ... Boris Lushniak , says that "skin cancer is a ... too much exposure to indoor and outdoor ultraviolet light is ... Aesthetic Medicine, in Boca Raton, Florida , ...
(Date:7/30/2014)... BURLINGTON, Mass. , July 30, 2014 /PRNewswire/ ... United States preclinical animal research imaging ... trend toward multimodality imaging, such as combining computed ... and optical imaging. This demand stems from the ... publication requirements among scientific journals, which will spur ...
(Date:7/30/2014)... Cynosure, Inc. (NASDAQ: CYNO ), a ... minimally invasive applications, today announced that the Board of Directors ... Financial Officer Timothy W. Baker to President of ... to serve as CFO and will take the title of ... Chief Executive Officer. "Tim has been a ...
Breaking Medicine Technology:Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market 2Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2
... FDA, Favorable Scientific Advice from EMEA and Phase 3 Plans ... Cell Lung ... Dr. Giuseppe Giaccone,Chief of the Medical Oncology Branch at the ... Phase 2 trial with talactoferrin alfa in non-small cell,lung cancer ...
... End-User Satisfaction, ... of Care Improvements, ORLANDO, Fla., Feb. 25 ... Society (HIMSS) 2008 Annual,Conference and Exhibition in Orlando, ... faith-based healthcare system in Nebraska and southwestern,Iowa, announced ...
Cached Medicine Technology:Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 2Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 3Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 4Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 5Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 6Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 7Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 2Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 3Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 4Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 5
(Date:7/31/2014)... York City, NY (PRWEB) July 31, 2014 ... hot chocolate , will be available in New York's ... Company in August. BRC is known for their commitment ... the Associated Press. , Chocolatto® is the new sensation ... Italian hot chocolate ! A delicious highly popular Italian ...
(Date:7/31/2014)... Thanks to its mildly sweet flavor ... been used as a medium for delivery of ... However consistent, dependable sourcing of erythritol often fluctuates. ... and beverage manufacturers’ increasing needs for reliable, dependable, ... ErysweetTM Erythritol. , “Erysweet is unique in ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The study, ... explores variation in Medicare episode of care payments for ... pneumonia, and major joint replacements (hips and knees). ... Medicare’s Bundled Payments for Care Improvement program, the study ... least expensive regions in the country. , “Our study ...
(Date:7/30/2014)... Vail and Beaver Creek, Colo., skiers have ... “Blind Skier.” Those skiers and guides are enjoying time ... , a non-profit organization founded in 2001 that matches ... for snow sport opportunities. Visually impaired skiers and snowboarders ... pick up an application to participate in the program ...
(Date:7/30/2014)... Calling all runners in the Richmond, VA region. , Tidewater ... monthly Runner’s Injury Clinic at the Glen Allen ... Monday of each month through the end of the year ... December 8. , The clinics run from 5:30 to ... and attire, will receive a complimentary evaluation of running injuries ...
Breaking Medicine News(10 mins):Health News:Dolce Vite Chocolatto® - World's Best Thick Dark Italian Hot Chocolate Now Available at NYC's Favorite Cafe Brooklyn Roasting Company 2Health News:Steviva Ingredients Launches Erysweet Erythritol 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 3Health News:Colorado Non-Profit Foresight Ski Guides Seeking Applications for Blind and Visually Impaired Skiers and Guides for Vail Ski Season 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 3
... CGCP), announced that the company will release,results for its ... prior,to market open on Tuesday, March 4, 2008. The ... Vice President and Chief Financial,Officer William R. Abbott will ... Eastern time (9:00 a.m. Pacific time) to review the ...
... new low-fat ice cream dipped in chocolate, OAKLAND, ... The Skinny Cow(R) brand urges dieters everywhere to release ... in at just 80 calories per pop, the perfectly-portioned,chocolate-dipped ... and refreshing mint flavors. Skinny Dippers contain no trans ...
... February 12 Aircraft Medical ("Aircraft"),announces that it ... validity of its European Patent No. 1307131 (the ... in the Edinburgh Court of,Session action will result ... has also lodged defences at the Court of ...
... seek any assistance, MORAGA, Calif., Feb. 12 ... disorders, it is regularly under diagnosed,by medical professionals, according ... million people affected every year., Most of us ... fatigue, or trembling -- before important events such as,exams, ...
... Medical Centers (BMC) New England Centenarian Study report ... subjects, avoiding age-related diseases (i.e. stroke, cardiovascular disease, ... longevity; rather, the avoidance of disability may be ... findings appear in the February 11th issue of ...
... Institute,s new CWC Program bridges the gap between fitness ... effort to reduce health care costs in America, ... a Certified Wellness Coach (CWC) program that bridges,the gap ... CWC provides a vast variety of learning objectives. ...
Cached Medicine News:Health News:Cardiogenesis Corporation to Report 2007 Fourth Quarter and Year-End Results on March 4th 2Health News:Dip Your Diet in Chocolate ... Introducing New Skinny Dippers! 2Health News:Aircraft Medical Files Counter Action Against Verathon 2Health News:40 Million Americans Endure Anxiety Everyday 2Health News:Researchers at BMC find disability does not necessarily follow disease in living to old age 2Health News:Spencer Institute Announces Wellness Coaching: Innovative Certification Training for Life Coaching 2
... Finnpipette BioControl multichannel has ... as the single channel ... fits allseven multichannel and ... cone modules. Both pipettes ...
... and best value in high performance electronic ... ultra lightweight design reduce hand fatigue and ... lever tip ejector , Color coding for ... or for greater performance use Hamilton AdvanTip ...
... pro Electronic Pipette is ideal for all ... easy-to-follow display, ergonomically-placed operating buttons, and various ... pipetting and diluting make this a lab ... of a manual pipette without any adverse ...
... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...
Medicine Products: